- Lapatinib : Overview and Current Role in Metastatic Breast Cancer
-
Chan A
- KMID: 2166046
- Cancer Res Treat.
- 2006 Dec;38(4):198-200.
No Author listed. -
- CITED
-
- Close
- SHARE
-
- Close
- Hypersensitivity Reactions to Oxaliplatin
-
Lee KH, Park YJ, Kim ES, Hwang HJ, Shim BY, Kim HK
- KMID: 2166054
- Cancer Res Treat.
- 2006 Dec;38(4):240-241.
Oxaliplatin is a third-generation platinum compound that is used as a single agent and in combination with fluorouracil (5-FU) to treat colorectal and gastric carcinoma. The patients treated with oxaliplatin... -
- CITED
-
- Close
- SHARE
-
- Close
- Mouse Orthotopic Lung Cancer Model Induced by PC14PE6
-
Cui ZY, Ahn JS, Lee JY, Kim WS, Lim HY, Jeon HJ, Suh SW, Kim JH, Kong WH, Kang JM, Nam DH, Park K
- KMID: 2166053
- Cancer Res Treat.
- 2006 Dec;38(4):234-239.
PURPOSE: This study was undertaken to investigate in detail the xenograft mouse orthotopic lung cancer model induced by PC14PE6 adenocarcinoma cells. MATERIALS AND METHODS: Three cell doses (0.5x10(6); 1x10(6); 2x10(6)) of... -
- CITED
-
- Close
- SHARE
-
- Close
- An Evaluation of Nutrition Support for Terminal Cancer Patients at Teaching Hospitals in Korea
-
Kim DY, Lee SM, Lee KE, Lee HR, Kim JH, Lee KW, Lee JS, Lee SN
- KMID: 2166049
- Cancer Res Treat.
- 2006 Dec;38(4):214-217.
PURPOSE: We wanted to analyze the use of nutrition support for terminal cancer patients, the effect of discussing withdrawal of nutrition support and do-not- resuscitate (DNR) consent on the use... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Significance of Immunohistochemical Expression of p53 Gene Product in Operable Breast Cancer
-
Song HS, Do YR, Kang SH, Jeong KY, Kim YS
- KMID: 2166050
- Cancer Res Treat.
- 2006 Dec;38(4):218-223.
PURPOSE: The aim of this study was to investigate the prognostic significance of the expression of p53 gene product in operable invasive breast cancer by performing immunohistochemical analysis. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Angiogenesis: Initiation and Targeting : Therapeutic Targeting of an FGF-Binding Protein, an Angiogenic Switch Molecule, and Indicator of Early Stages of Gastrointestinal Adenocarcinomas
-
Tassi E, Wellstein
- KMID: 2166045
- Cancer Res Treat.
- 2006 Dec;38(4):189-197.
Tumor angiogenesis has been related to the initiation as well as progression toward more aggressive behavior of human tumors. In particular, the activity of angiogenic factors is crucial for tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Gemcitabine Single or Combination Chemotherapy in Post Anthracycline and Taxane Salvage Treatment of Metastatic Breast Cancer: Retrospective Analysis of 124 Patients
-
Kim MK, Kim SB, Ahn JH, Lee SI, Ahn SH, Son BH, Gong G, Kim HH, Lee JS, Kang YK, Kim WK
- KMID: 2166048
- Cancer Res Treat.
- 2006 Dec;38(4):206-213.
PURPOSE: To evaluate the efficacy of gemcitabine- based chemotherapy, particularly in patients with anthracycline- and taxane-pretreated 2(nd)-line or greater metastatic breast cancer, and to compare gemcitabine monotherapy (G) with two... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Oxaliplatin, 5-fluorouracil, and Leucovorin in Relapsed or Metastatic Colorectal Cancer as Second Line Therapy
-
Lee DJ, Oh HS, Choi JH, Lee YY, Kim IS, Ahn MJ
- KMID: 2166047
- Cancer Res Treat.
- 2006 Dec;38(4):201-205.
PURPOSE: The purpose of the study was to assess the efficacy and safety of biweekly oxaliplatin in combination with leucovorin (LV)-modulated bolus plus infusion of 5-fluorouracil (5-FU) in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- p53 Prevents Immature Escaping from Cell Cycle G2 Checkpoint Arrest through Inhibiting cdk2-dependent NF-Y Phosphorylation
-
Yun UJ, Park HD, Shin DY
- KMID: 2166051
- Cancer Res Treat.
- 2006 Dec;38(4):224-228.
PURPOSE: Recent studies have suggested that p53 regulates the G2 checkpoint in the cell cycle and this function is required for the maintenance of genomic integrity. In this study, we... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Pentoxifylline on Radiobiological Parameters in the Rat Radiation Myelopathy
-
Kim WD, Park WY
- KMID: 2166052
- Cancer Res Treat.
- 2006 Dec;38(4):229-233.
PURPOSE: There is great recent interest in the potential value of using pentoxifylline (3,7-dimethyl-1(5-oxyhexyl)- xanthine, PTX) as an inhibitor of radiation-induced late normal tissue damage. The effects of PTX on... -
- CITED
-
- Close
- SHARE
-
- Close
